Showing results (291-300 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|March 20, 2025
Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunityLiang Zhou, Guangyu Lian, Tao Zhou, et al.Nature Cancer|March 19, 2025
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancerHanling Wang, Sulin Zhang, Qiang Pan, et al.Nature Cancer|May 1, 2025
PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunityLin Xia, Jun-Yi Liu, Chao Yu, et al.Nature Cancer|June 5, 2023
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRASYuta Adachi, Ryo Kimura, Kentaro Hirade, et al.Nature Cancer|February 18, 2026
The automated computational workflow QUICHE reveals structural definitions of antitumor responses in triple-negative breast cancerJolene S Ranek, Noah F Greenwald, Mako Goldston, et al.Nature Cancer|May 29, 2023
Understanding inequities in precision oncology diagnosticsRitika Dutta, Mounica Vallurupalli, Quinn McVeigh, et al.Nature Cancer|March 11, 2026
Prospective evaluation of artificial intelligence integration into breast cancer screening in multiple workflow settings: the GEMINI studyClarisse Florence de Vries, Gerald Lip, Roger Todd Staff, et al.Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.Nature Cancer|February 14, 2024
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trialEvanthia T Roussos Torres, Won J Ho, Ludmila Danilova, et al.Nature Cancer|March 5, 2024
A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitorsSungjoon Park, Erica Silva, Akshat Singhal, et al.Pageof 65